What is MCAS?
Generally speaking, Mast Cell Activation Syndrome (MCAS) is a condition where mast cells get activated (duh). Mast cells are:
allergy cells responsible for immediate allergic reactions. They cause allergic symptoms by releasing products called “mediators” stored inside them or made by them. In allergic reactions, this release occurs when the allergy antibody IgE, which is present on the mast cell surfaces, binds to proteins that cause allergies, called allergens. This triggering is called activation, and the release of these mediators is called degranulation.
People can have too many mast cells (Mastocytosis AKA what Rachel Rose has) or these cells can be wonky and release IgE when they shouldn't (AKA MCAS). For those of us with MCAS, we get hit with mild versions of anaphylaxis or other symptoms in response to exposure to everyday things that others aren't allergic to or without a clear cause. MCAS symptoms usually include things like:
- Mental: brain fog, panic attacks, anxiety, feeling dread
- GI: abdominal cramps, nausea, vomiting, diarrhea, constipation
- Cardiovascular: high pulse/tachycardia, palpitations, high or low blood pressure, syncope (passing out, fainting) or nearly doing so, being lightheaded or dizzy
- Dermatological: flushing, hives, itching, welts from scratches
- Respiratory: wheezing, shortness of breath, chronic congestion, coughing, struggling to breathe deeply
- Vision: blurry vision, eyes that struggle with being dry or red or watery
- Auditory: sensitivity to sounds, tinnitus
- Pain: join pain, chest/abdominal pain, deep bone pain
- Migraines, headaches
- Other: Weight gain and retention despite low-calorie intake and exercise, takes longer to heal wounds, smell things others can't
If these build up or someone is in a space with many triggers, they may experience anaphylaxis:
- Difficulty breathing
- Itchy hives
- Feeling too warm
- Weak, rapid pulse
- Nausea, vomiting, diarrhea
- Lightheadedness, dizziness, fainting
I personally have reactions to things such as:
- Cleaning chemicals
- Heavy fragrances
- Red dye
- Some forms of exercise
- Skin friction or pressure
- Bug bites
- Stress, emotional distress
- Changes in humidity, barometric pressure, temperature
Mast Cell Mediators include:
- Adenosine triphosphate
- Chemokines, such as eosinophil chemotactic factor
- Cytokines, such as TNF-α, basic fibroblast growth factor, interleukin-4, stem cell factor
- Eicosanoids, such as thromboxane, prostaglandin D2, leukotriene C4, and platelet-activating factor
- Histamine
- Leukotriene
- Lysosomal enzymes, such as β-hexosaminidase, β-glucuronidase, and arylsulfatases
- Prostaglandin
- Proteoglycan
- Serine protease, such as tryptase
- Serotonin
From The Mast Cell Society, Inc:
Mast cell diseases are caused by the proliferation and accumulation of genetically altered mast cells and/or the inappropriate release of mast cell mediators, creating symptoms in multiple organ systems.2 The three major forms of mast cell diseases are mastocytosis, mast cell activation syndrome (MCAS), and Hereditary Alpha tryptasemia (HAT). Mast cell diseases can cause tremendous suffering and disability due to symptomatology from daily mast cell mediator release, and/or symptoms arising from infiltration and accumulation of mast cells in major organ systems. Although systemic mastocytosis is a rare disease,3 those suffering with MCAS have recently been increasingly recognized and diagnosed. As a result, patients with MCAS appear to represent a growing proportion of the mast cell disease patient population.4, 5 It is important to note that the process of mast cell activation can occur in anyone, even without a mast cell disease, as well as in patients with both mastocytosis and MCAS.6
Existence of a subset of mast cell disease patients who experience episodes of mast cell activation without detectable evidence of a proliferative mast cell disease was postulated over 20 years ago.19, 20 Over the last two decades, with development of improved methodology for identification of abnormal mast cells,21-24 it became apparent that there were patients who exhibited symptoms of mast cell mediator release who did not fulfill the criteria for SM.25, 26 Thus began the evolution of discussions about other forms of mast cell diseases, both clonal and nonclonal, which became known as Mast Cell Activation Syndromes (MCAS).6, 27, 28
Diagnosis and Proposed Classification
Recognition by specialist physicians of the importance of mast cell activation in disease led to an international Mast Cell Disorders Working Conference emphasizing this topic in September of 2010. Consensus statements were published regarding classification of and diagnostic criteria for mast cell diseases,6 where mast cell activation plays a prominent role.
Mediators produced by mast cells have a considerable effect on specific symptomatology. Symptoms, including, but not limited to flushing, pruritis (itching), urticaria (hives), headache, gastrointestinal symptoms (including diarrhea, nausea, vomiting, abdominal pain, bloating, gastroesophageal reflux), and hypotension (low blood pressure), allow a patient to meet the first of three required co-criterion for systemic mast cell activation when the patient exhibits symptoms involving two or more organ systems in parallel, which recur, or are chronic, are found not to be caused by any other condition or disorder other than mast cell activation, and require treatment or therapy.6, 28
The second required co-criterion for systemic mast cell activation depends on documentation that mast cells are directly involved in the symptomatology. An increase in the serum level of tryptase, above baseline and within a narrow (generally accepted as one to two hour) window of time after a symptomatic episode, is proposed as the preferred method for providing evidence of mast cell involvement according to these criteria.6, 28-30 The consensus article provides a method for calculating the required minimum rise in serum tryptase.6 After a reaction, a level of serum tryptase that is a minimum of 20% above the basal serum tryptase level, plus 2 ng/ml, will meet the second criterion listed above for a mast cell activation event (see Tests for further information). Consensus members also agreed that when serum tryptase evaluation is not available or when the tryptase level does not rise sufficiently to meet the required increase for the co-criterion, other mediator tests could suffice. A rise in urinary n-methyl histamine, prostaglandin-D2, or its metabolite, 11β-prostaglandin-F2α (24-hour urine test for any of the three), is considered an alternative for the co-criterion related to a requirement for a mast cell mediator level rise during a systemic mast cell activation event.6
Finally, the third co-criterion requires a response (based on response criteria15) to medications that inhibit the action of histamine.6 In addition, in those with typical mast cell activation symptoms, a “complete or major” response to drugs that inhibit other mediators produced by mast cells or block mast cell mediator release can be regarded as fulfillment of the third co-criterion for MCAS.6, 28
Types of MCAS
From The Mast Cell Society, Inc:
Primary MCAS
Primary MCAS results from a clonal population of mast cells, where a genetic alteration in the cells exists, and may be due to mastocytosis or to monoclonal Mast Cell Activation Syndrome (MMAS). Primary MCAS with mastocytosis can be diagnosed if the patient fulfils criteria for MCAS and fulfills the WHO criteria for mastocytosis. MMAS is a distinct disease characterized by the presence of abnormal mast cells and fulfillment of criteria for MCAS, but where sufficient criteria for a diagnosis of mastocytosis are not identified.1-10
Secondary MCAS
Secondary MCAS is diagnosed when mast cell activation occurs as an indirect result of another disease or condition.1-3, 9, 11 Physician awareness of the presence of secondary MCAS will allow for more appropriate mast cell activation-targeted treatments, in addition to primary disease-related medications, to be provided. In addition to the widespread example of IgE-dependent allergy as a cause of secondary MCAS, other diseases that can cause secondary MCAS have been reviewed in the literature.1-3, 11
Idiopathic MCAS
Idiopathic MCAS is proposed as a final diagnosis after proposed MCAS criteria have been fulfilled and a thorough evaluation has excluded the possibility of another known underlying cause for this activation.2, 12 Idiopathic MCAS is therefore nonclonal, with regard to current diagnostic capabilities related to mast cell analyses, and has been presented and discussed in the literature by a variety of mast cell disease specialists.1-3, 9-13 Review of other causes of MCAS to aid physicians in evaluation for the exclusionary diagnosis of idiopathic MCAS have also been provided.1-3, 10
BTW: Idiopathic just means of unknown origin:
Dr. House (S1E17): "Idiopathic," from the Latin, meaning we're idiots 'cause we can't figure out what's causing it.
Symptoms and Triggers of MCAS
Some Common Potential Triggers of MCAS
- Heat, cold, or sudden temperature changes
- Stress: emotional, physical, including pain, or environmental (i.e., weather changes, pollution, pollen, pet dander, etc.)
- Exercise
- Fatigue
- Food or beverages, including alcohol and alcohol-based sugars
- Drugs such as opioids, NSAIDs, antibiotics, general anesthesia, and some local anesthetics
- Dyes, including contrast dyes
- Natural odors, chemical odors, perfumes, and scents
- Heavy chemicals such as bleach
- Venoms (bee, wasp, mixed vespids, spiders, fire ants, jellyfish, snakes, biting insects, such as flies, mosquitos, and fleas, etc.)
- Infections (viral, bacterial, or fungal)
- Mechanical irritation, friction, vibration
- Sun/sunlight
Symptoms of Mast Cell Mediators Being Released
- Anaphylaxis
- Flushing of the face, neck, and chest
- Itching, rash, hives
- Swelling
- Itchy nose, congestion, post-nasal drip
- Wheezing, shortness of breath, stridor (a harsh vibrating sound when breathing)
- Throat itching, swelling, hoarse voice, increased mucous production
- Eye-watering, itching, redness, blurry, inflammation
- Headache, brain fog, cognitive dysfunction, anxiety, depression
- Diarrhea, nausea, vomiting, abdominal pain, bloating, acid reflux
- Food moving too quickly through you (dumping syndrome)
- Bone pain, muscle pain, osteosclerosis, osteopenia, osteoporosis
- Lightheadedness, syncope/fainting, almost fainting
- Numb or tingly skin
- persistent redness or white marks after scratching the skin
- Irritation, mood swings
- Fatigue, malaise
- Mouth burning, gum inflammation
- Struggling to modulate temperature
- Genital pain, swelling, pain when urinating (similar to a UTI), vaginal pain, discharge, having to pee often
- Rapid heart rate, chest pain
- Low blood pressure, high blood pressure at the start of a reaction, blood pressure instability
- Uterine cramps or bleeding
This Becomes Anaphylaxis When...
- Itching/swelling of lips, tongue
- Itching throat, tightness, hoarseness
- Itching skin, hives, redness, swelling
- Vomiting, diarrhea, cramps
- Shortness of breath, coughing, wheezing
- Weak pulse, dizziness, passing out
Sources & Resources
- Mast Cell Action: Diagnosing MCAS
- TMS: Symptoms and Triggers of MCAS
- from Mast Attack:
- Anticholinergic use and dementia
- Fragrance Allergy
- Histamine effects on neurotransmitters (serotonin, dopamine and norepinephrine)
- Mast cell mediators: Prostaglandin D2 (PGD2)
- Mast cells and metabolic syndrome: Hypertension, obesity and atherosclerosis
- Mast cells in nerve pain
- MCAS: Anemia and deficiencies
- MCAS: Blood, bone marrow and clotting
- MCAS: Effects on eyes, ears, nose and mouth
- MCAS: GI Symptoms and Liver Abnormalities
- MCAS: Kidney, urinary and genital concerns
- MCAS: Neurologic and psychiatric symptoms
- MCAS: Pain
- MCAS: Respiratory symptoms
- Neuropsychiatric features of mast cell disease: Part 1 of 2
- Neuropsychiatric features of mast cell disease: Part 2 of 2
Treatment & Management
Antihistamines
Histamine 1 blockers
These medications help with itching, abdominal pain, flushing, headaches, brain fog, and general mast cell stability.
- Diphenhydramine, Benadryl, Diphen, Banophen, Genahist
- Cyproheptadine, Periactin
- Hydroxyzine, Vistaril, Atarax
- Doxepin Hydrochloride, Doxepin, Sinequan
- Chlorpheniramine, Chlor-Trimeton, Aller-Chlor, Ed-Chlortan
- Loratadine, Claritin, Alavert
- Fexofenadine, Allegra
- Cetirizine, Zyrtec
- Levocetirizine, Xyzal
- Desloratadine, Clarinex
Histamine 2 blockers
These medications help with gastrointestinal symptoms and overall mast cell stability.
- Famotidine, Pepcid
- Cimetidine, Tagamet
- Nizatadine, Axid
Mast Cell Stabilizers
- Cromolyn sodium, Gastrocrom (oral solution), Nasalcrom (nasal spray)
- Ketotifen, Zaditor (eye drops)
- Bioflavonoids such as quercetin and luteolin
Other Medications
- Aspirin blocks the production of prostaglandin D2 (released from mast cells), helps limit flushing as well as brain fog and bone pain
- Montelukast (Singular) and Zafirlukast (Accolate) block leukotriene C4 effects - and Zileuton (Zyflo/Zyflo CR) blocks its production - so these can reduce wheezing, abdominal cramping, stomach and GI upset, overall mast cell stability
- Omalizumab (Xolair) blocks the binding of IgE to receptors and can be helpful to reduce sensitivity and anaphylaxis; can help with asthma, anaphylaxis, and overall mast cell stability
- Corticosteroids such as prednisone can be helpful to mitigate the effects of reactions but aren't ideal to use longer-term
- Vitamin C helps break down histamine and contributes to overall mast cell stability
- Vitamin D suppresses antibodies binding to mast cells thus preventing inflammatory responses
- Probiotics can help control histamine levels, provided you're not allergic to them
- Magnesium can help control mast cell division and histamine production
Additional Things to Consider
- Many people with MCAS struggle with heartburn or reflux and therefore find it helpful to also be on a Proton Pump Inhibitor such as Prilosec (omeprazole)
- Some folks do well with a Low-FODMAP Diet or a Low-Histamine Diet to help control some GI and other reactions
Sources & Resources
MCAS and Sex
- Sex and chronic illness
- Sex and chronic illness series: vaginal pain
- The Sex Series – Part One: Kissing and allergic reactions
- The Sex Series – Part Two: Contact dermatitis
- The Sex Series – Part Three: Allergic reactions of the vagina and vulva
- The Sex Series – Part Four: Seminal allergy
- The Sex Series – Part Five: Seminal allergy, post-orgasmic illness syndrome and burning semen syndrome
- The Sex Series – Part Six: Male pelvic dysfunction and mast cells
- The Sex Series – Part Seven: Mast cell activation and anal penetration
- The Sex Series – Part Eight: Female pelvic floor dysfunction (1 of 2)
- The Sex Series – Part Nine: Female pelvic floor dysfunction (2 of 2)
Experiences
Posts & Articles
- Accessibility: A Beginner’s Guide to Fragrance and Chemical Sensitivities
- Anaphylaxis and mast cell attacks
- Exercise and mast cell activity
- Histamine effects on neurotransmitters (serotonin, dopamine and norepinephrine)
- How I received a mast cell activation syndrome diagnosis
- How my mast cell activation syndrome diagnosis was diagnosed and reconfirmed
- How to travel with mast cell disease
- I think I might have mast cell disease: FAQ
- Leptin: the obesity hormone released by mast cells
- Living with MCAS (mast cell activation syndrome)
- Low Histamine Recipes
- Mast cell disease fact sheet
- Mast cell disease in families
- Mast cell food reactions and the low histamine diet
- Mast cells and cardiac and vascular dysfunction
- MCAS: Neurologic and psychiatric symptoms
- Medical Info Cards: An Organization System for Complex Illness
- My 5 main triggers for mast cell activation and how I manage them
- My journey to a mast cell activation syndrome diagnosis
- Quercetin for MCAS
- Surgery and emergency care
- Trying to calm down a MCAS flare-up: being quiet and reducing stress
- What I Could Tell You About Mast Cell Disease
- What’s it really like to have MCAS?
Blogs & Sites
Podcasts
Comorbidities
Ehlers-Danlos Syndrome
Articles & Toolkits
Research
- Byers PH. Vascular Ehlers-Danlos Syndrome. 1999 Sep 2 [updated 2019 Feb 21]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. PMID: 20301667.
- Inayet N, Hayat JO, Kaul A, Tome M, Child A, Poullis A. Gastrointestinal Symptoms in Marfan Syndrome and Hypermobile Ehlers-Danlos Syndrome. Gastroenterol Res Pract. 2018 Jul 29;2018:4854701. doi: 10.1155/2018/4854701. PMID: 30151001; PMCID: PMC6087563.
- Levy HP. Hypermobile Ehlers-Danlos Syndrome. 2004 Oct 22 [Updated 2018 Jun 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021.
- Malfait F, Wenstrup R, De Paepe A. Classic Ehlers-Danlos Syndrome. 2007 May 29 [updated 2018 Jul 26]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. PMID: 20301422.
- Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, Levy H. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history. Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):48-69. doi: 10.1002/ajmg.c.31538. Epub 2017 Feb 1. PMID: 28145611. (pdf)
- Yew KS, Kamps-Schmitt KA, Borge R. Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders. Am Fam Physician. 2021 Apr 15;103(8):481-492. PMID: 33856167.
Organizations
- I do not recommend the EDS Society. Click here to learn why.
- Hypermobility Syndrome Association
Forms of Dysautonomia
POTS: Postural Orthostatic Tachycardia Syndrome
- What is POTS?
- What is POTS? (video)
- Postural Orthostatic Tachycardia Syndrome
- What Is Postural Orthostatic Tachycardia Syndrome (POTS)?
- What’s it really like to have POTS?
- A Tale of Two Syndromes – POTS and MCAS
- Doherty, Taylor A., and White, Andrew A. Postural orthostatic tachycardia syndrome and the potential role of mast cell activation,
Autonomic Neuroscience, Volume 215, 2018, Pages 83-88, ISSN 1566-0702, https://doi.org/10.1016/j.autneu.2018.05.001. - Kohno R, Cannom DS, Olshansky B, et al. Mast cell activation disorder and postural orthostatic tachycardia syndrome: A clinical association. Journal of the American Heart Association. 2021;10(17). doi:10.1161/jaha.121.021002
- Shibao C, Arzubiaga C, Roberts LJ 2nd, Raj S, Black B, Harris P, Biaggioni I. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension. 2005 Mar;45(3):385-90. doi: 10.1161/01.HYP.0000158259.68614.40. Epub 2005 Feb 14. PMID: 15710782.
Other Forms of Dysautonomia
- Autoimmune Autonomic Ganglionopathy
- Autonomic Dysreflexia
- Baroreflex Failure
- Cerebral Salt Wasting Syndrome
- Diabetic Autonomic Neuropathy
- Familial Dysautonomia
- Inappropriate Sinus Tachycardia
- Multiple System Atrophy
- Neurocardiogenic Syncope/Vasovagal Syncope
- Panayiotopoulos Syndrome
- Pure Autonomic Failure
- Reflex Sympathetic Dystrophy (Complex Regional Pain Syndrome)
Articles
- Understanding Dysautonomia
- Why Dysautonomia Is Often Misdiagnosed
- Diagnosing and Treating Dysautonomia
- Medical Tests for Measuring Dysautonomia
- The Anatomy of the Autonomic Nervous System
Organizations
Journal Articles & Research
- Afrin LB. Some cases of hypermobile Ehlers-Danlos syndrome may be rooted in mast cell activation syndrome [published online ahead of print, 2021 Oct 31]. Am J Med Genet C Semin Med Genet. 2021;10.1002/ajmg.c.31944. doi:10.1002/ajmg.c.31944
- Afrin LB. Presentation, diagnosis and management of mast cell activation syndrome. In: Murray DB, editor. Mast cells: phenotypic features, biological functions and role in immunity. Hauppauge: Nova Science Publishers, Inc.; 2013. p. 155-232.
- Afrin LB, Self S, Menk J, Lazarchick J. Characterization of Mast Cell Activation Syndrome. Am J Med Sci. 2017;353(3):207-215. doi:10.1016/j.amjms.2016.12.013.
- Afrin LB. Mast cell activation disease and the modern epidemic of chronic inflammatory disease. Translational Research. 2016 Aug;174;33-59. http://dx.doi.org/10.1016/j.trsl.2016.01.003
- Afrin LB, Pöhlau D, Raithel M, Haenisch B, Dumoulin FL, Homann J, Mauer UM, Harzer S, and Molderings GJ. Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases. Brain, Behavior, and Immunity. 2015 Jul;50; 314-321. http://dx.doi.org/10.1016/j.bbi.2015.07.002
- Afrin LB, Wan Z, Hill EG. Characterization Of Common Blood Test Abnormalities Potentially Aiding Diagnosis Of Mast Cell Activation Syndrome: A Preliminary Analysis. Blood 2013; 122 (21): 5240. doi: https://doi.org/10.1182/blood.V122.21.5240.5240
- Akin C. Mast cell disorders. UpToDate entry. Updated: Apr. 03, 2020.
- Akin C, Metcalfe DD. Mastocytosis and mast cell activation syndromes presenting as anaphylaxis. In: Castells MC, editor. Anaphylaxis and hypersensitivity reactions. New York: Humana Press; 2011. p. 245-56.
- Akin C, Valent P, Metcalfe DD. Mast cell activation syndrome: proposed diagnostic criteria. J Allergy Clin Immunol. 2010 Dec;126(6):1099-104 e4.
- Arock M, Sotlar K, Gotlib J, Sperr WR, Hartmann K, Schwartz LB, Akin C, Horny H, and Valent P. New developments in the field of mastocytosis and mast cell activation syndromes: a summary of the Annual Meeting of the European Competence Network on Mastocytosis (ECNM) 2019. Leuk Lymphoma. 2020 May;61(5): 1075-1083. doi: 10.1080/10428194.2019.1703974
- Bonadonna P, Pagani M, Aberer W, Bilo MB, Brockow K, Oude Elberink H, et al. Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper. Allergy. 2015 Jul;70(7):755-63.
- Bonamichi-Santos R, Yoshimi-Kanamori K, Giavina-Bianchi P, Vivolo Aun M. Association of Postural Tachycardia Syndrome and
Ehlers-Danlos Syndrome with Mast Cell Activation Disorders. Immunol Allergy Clin N Am. 2018;38:497-504. - Brock I, Prendergast W, Maitland A. Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder [published online ahead of print, 2021 Nov 7]. Am J Med Genet C Semin Med Genet. 2021;10.1002/ajmg.c.31940. doi:10.1002/ajmg.c.31940
- Butterfield JH. Survey of Mast Cell Mediator Levels from Patients Presenting with Symptoms of Mast Cell Activation. Int Arch Allergy Immunol. 2020;181:43-50. doi: 10.1159/000503964
- Butterfield JH, Weilder CR. The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome. J Allergy Clin Immunol Pract. 2020.
- Butterfield JH, Weiler CR. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production. Int Arch Allergy Immunol. 2008;147(4):338-43.
- Castells M. Mast cell mediators in allergic inflammation and mastocytosis. Immunol Allergy Clin North Am. 2006 Aug;26(3):465-85.
- Christ P, Sowa AS, Froy O and Lorentz A. The Circadian Clock Drives Mast Cell Functions in Allergic Reactions. Front. Immunol. 2018;9:1526. doi: 10.3389/fimmu.2018.01526
- Chung BY, Park SY, Byun YS, et al. Effect of Different Cooking Methods on Histamine Levels in Selected Foods. Ann Dermatol. 2017;29(6):706-714. doi:10.5021/ad.2017.29.6.706
- Doherty, Taylor A., and White, Andrew A. Postural orthostatic tachycardia syndrome and the potential role of mast cell activation,
Autonomic Neuroscience, Volume 215, 2018, Pages 83-88, ISSN 1566-0702, https://doi.org/10.1016/j.autneu.2018.05.001. - Francis A, Fatovich DM, Arendts G, et al. Serum mast cell tryptase measurements: Sensitivity and specificity for a diagnosis of anaphylaxis in emergency department patients with shock or hypoxaemia. Emerg Med Australas. 2018;30(3):366-374. doi:10.1111/1742-6723.12875
- Frieri M, Patel R, Celestin J. Mast cell activation syndrome: a review. Curr Allergy Asthma Rep. 2013 Feb;13(1):27-32. doi: 10.1007/s11882-012-0322-z. PMID: 23179866.
- Folkerts J, Stadhouders R, Redegeld FA, Tam S-Y, Hendriks RW, Galli SJ and Maurer M. Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases. Front. Immunol. 2018;9:1067. doi: 10.3389/fimmu.2018.01067
- Giannetti MP, Akin C, Hufdhi R, Hamilton MJ, Weller E, Anrooij BV, Lyons JJ, Hornick JL, Pinkus G, Castells M, & Pozdnyakova O. Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology. Journal of Allergy and Clinical Immunology. 2021;147(4), 1497-1501.e1. https://doi.org/10.1016/j.jaci.2020.11.017
- Giannetti A, Filice E, Caffarelli C, Ricci G, and Pession A. Review: Mast Cell Activation Disorders. Medicina. 2021;57(124). doi: https://doi.org/10.3390/medicina57020124.
- Golden, DBK. The Many Faces of Mast Cell Disorders-A House of Mirrors? J Allergy Clin Immunol Pract. 2019 Apr;7;1139-41. https://doi.org/10.1016/j.jaip.2019.02.003
- Gülen T, Akin C, Bonadonna P, et al. Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review. J Allergy Clin Immunol Pract. 2021;9(11):3918-3928. doi:10.1016/j.jaip.2021.06.011
- Haenisch B, Molderings GJ. White matter abnormalities are also repeatedly present in patients with systemic mast cell activation syndrome. Translational Psychiatry. 2018;8. 95. DOI 10.1038/s41398-018-0143-5
- Hamilton MJ. Nonclonal Mast Cell Activation Syndrome: A Growing Body of Evidence. Immunol Allergy Clin North Am. 2018;38(3):469-481. doi:10.1016/j.iac.2018.04.002
- Jennings S, Slee VM, Finnerty CC, Hempstead JB, and Bowman AS. Symptoms of Mast Cell Activation: The Patient Perspective. Ann Allergy Asthma Immunol. 2021 Oct;127(4) 407-409. https://doi.org/10.1016/j.anai.2021.07.004
- Jennings S, Russell N, Jennings B, Slee V, Sterling L, Castells M, et al. The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions. J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):70-6.
- Kumaraswami S and Farkas G. Management of a Parturient with Mast Cell Activation Syndrome: An Anesthesiologist’s Experience. Case Reports in Anesthesiology. 2018 May. https://doi.org/10.1155/2018/8920921
- Leru PM, Anton VF, Ureche C, Zurac S, Bratu O, and Neagoe CD. Mast cell activation syndromes ‑ evaluation of current diagnostic
criteria and laboratory tools in clinical practice. Experimental and Therapeutic Medicine. 2020 June;20:2348-2351. DOI: 10.3892/etm.2020.8947 - Lythgoe MP, Krell J, McNeish IA, Tookman L. Safe administration of chemotherapy in mast cell activation syndrome. J Oncol Pharm Pract. 2021;27(4):1005-1010. doi:10.1177/1078155220953879
- Khokhar D, and Akin C. Mast Cell Activation: When the Whole is Greater than the Sum of Its Parts. Med Clin N Am. 2020; 104: 177-187. https://doi.org/10.1016/j.mcna.2019.09.002
- Kleij HP, Bienenstock J. Significance of Conversation between Mast Cells and Nerves. Allergy Asthma Clin Immunol. 2005;1(2):65-80. doi:10.1186/1710-1492-1-2-65.
- Kohn A, and Chang C. The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS). Clinical Reviews in Allergy & Immunology. 2020;58:273-297. https://doi.org/10.1007/s12016-019-08755-8
- Krystel-Whittemore M, Dileepan KN, Wood JG. Mast Cell: A Multi-Functional Master Cell. Front Immunol. 2016;6:620. Published 2016 Jan 6. doi:10.3389/fimmu.2015.00620
- Matito, A, Escribese MM, Longo N, Mayorga C, Luengo-Sánchez O, Pérez-Gordo M, Matheu V, Labrador-Horrillo M, Pascal M, Seoane-Reula ME. Clinical Approach to Mast Cell Activation Syndromes: A Practical Overview. J Investig Allergol Clin Immunol 2021; Vol. 31(6). doi: 10.18176/jiaci.0675
- Molderings GJ. The genetic basis of mast cell activation disease - looking through a glass darkly. Crit Rev Oncol Hematol. 2015 Feb;93(2):75-89. doi: 10.1016/j.critrevonc.2014.09.001. Epub 2014 Sep 28. PMID: 25305106.
- Molderings GJ, Haenisch B, Bogdanow M, Fimmers R, Nöthen MM. Familial occurrence of systemic mast cell activation disease. PLoS One. 2013;8(9):e76241. Published 2013 Sep 30.
- Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. J Hematol Oncol. 2011;4:10. Published 2011 Mar 22. doi:10.1186/1756-8722-4-10.
- Picard M, Giavina-Bianchi P, Mezzano V, and Castells M. Expanding Spectrum of Mast Cell Activation Disorders:
Monoclonal and Idiopathic Mast Cell Activation Syndromes. Clinical Therapeutics. 2013;35(5) 548-562. http://dx.doi.org/10.1016/j.clinthera.2013.04.001 - Rechenauer T, Raithel M, Götze T, Siebenlist G, Rückel A, Baenkler H-W, Hartmann A, Haller F and Hoerning A. Idiopathic Mast Cell Activation Syndrome With Associated Salicylate Intolerance. Front. Pediatr. 2018;6:73. doi: 10.3389/fped.2018.00073
- Regauer S. Mast cell activation syndrome in pain syndromes bladder pain syndrome/interstitial cystitis and vulvodynia. Translational Andrology and Urology. 2016;5(3):396-397. http://dx.doi.org/10.21037/tau.2016.03.12
- Romantowski, J.; Górska, A.; Niedoszytko, M.; Gulen, T.; Gruchała-Niedoszytko, M.; Nedoszytko, B.; Lange, M.; Brockow, K.; Arock, M.; Akin, C.; et al. A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders. Int.
J. Mol. Sci. 2021, 22, 1454. https://doi.org/10.3390/ijms22031454. - Romantowski J, Górska A, Lange M, Nedoszytko B, Gruchała‑Niedoszytko M, Niedoszytko M. How to diagnose mast cell activation syndrome: practical considerations. Pol Arch Intern Med. 2020;130 (4): 317-323 doi:10.20452/pamw.15212
- Russell N, Jennings S, Jennings B, Slee V, Sterling L, Castells M, Valent P, and Akin C. The Mastocytosis Society Survey on Mast Cell Disorders: Part 2—Patient Clinical Experiences and Beyond. J Allergy Clin Immunol Pract. 2019 Apr;7(4) 1157-1165. https://doi.org/10.1016/j.jaip.2018.07.032
- Seneviratne SL, Maitland A, Afrin LB. Mast cell disorders in Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet. 2017;175(1):226-236. doi:10.1002/ajmg.c.31555
- Shibao C, Arzubiaga C, Roberts LJ 2nd, Raj S, Black B, Harris P, Biaggioni I. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension. 2005 Mar;45(3):385-90. doi: 10.1161/01.HYP.0000158259.68614.40. Epub 2005 Feb 14. PMID: 15710782.
- Theoharides TC, Valent P, Akin C. Mast Cells, Mastocytosis, and Related Disorders. N Engl J Med. 2015 Jul 9;373(2):163-72.
- Theoharides TC, Tsilioni I, Ren H. Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?. Expert Rev Clin Immunol. 2019;15(6):639-656.
- Valent P, Akin C, Nedoszytko B, Bonadonna P, Hartmann K, Niedoszytko M, Brockow K, Siebenhaar F, Triggiani M, Arock M, Romantowski J, Górska A, Schwartz LB, and Metcalfe DD. Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine. Int. J. Mol. Sci. 2020, 21, 9030; doi:10.3390/ijms21239030
- Valent P, and Akin C. Doctor, I Think I Am Suffering from MCAS: Differential Diagnosis and Separating Facts from Fiction. J Allergy Immunol Pract. 2019;7;1109-14. https://doi.org/10.1016/j.jaip.2018.11.045
- Valent P, Akin C, Bonadonna P, et al. Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome. The Journal of Allergy and Clinical Immunology: In Practice. 2019;7(4). doi:10.1016/j.jaip.2019.01.006
- Valent P, Akin C, Arock M, Brockow K, Butterfield JH, Carter MC, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol. 2012;157(3):215-25.
- Valent P, Akin C, Sperr WR, Horny HP, Metcalfe DD. Mast cell proliferative disorders: current view on variants recognized by the World Health Organization. Hematol Oncol Clin North Am. 2003 Oct;17(5):1227-41. doi: 10.1016/s0889-8588(03)00089-3. PMID: 14560784.
- Sabato V, Moïsec M, Blank U, Ebo DG, Vitte, J. Mast cell activation syndrome: is anaphylaxis part of the phenotype? A systematic review. Current Opinion in Allergy and Clinical Immunology. 2021 Oct;21(5)426-434 doi: 10.1097/ACI.0000000000000768
- Weiler CR, Asten KF, Akin C, Barkoff MS, Bernstein JA, Bonadonna P, et al. AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management. J Allergy Clin Immunol. Oct 2019; 144(4):883-896.
- Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in Long-COVID [published online ahead of print, 2021 Sep 23]. Int J Infect Dis. 2021;112:217-226. doi:10.1016/j.ijid.2021.09.043
- Weinstock LB, Brook JB, Blasingame KE, Kaleem Z, Afrin LB, Molderings GJ. Tinnitus in Mast Cell Activation Syndrome: A Prospective Survey of 114 Patients. Journal of Otolaryngology and Neurotology Research. 2021 Jan;4(1) 92-96.
- Weinstock LB, Walters AS, Brook JB, Kaleem Z, Afrin LB, Molderings GJ. Restless legs syndrome is associated with mast cell activation syndrome. J Clin Sleep Med. 2020;16(3):401–408.
- Weinstock LB, Brook JB, Myers TL, Goodman B. Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment. BMJ Case Rep. 2018. doi:10.1136/bcr-2017-221405
- Wilder-Smith CH, Drewes AM, Materna A, and Olesen SO. Symptoms of mast cell activation syndrome in functional gastrointestinal disorders. Scandinavian Journal of Gastroenterology. 2019;54(11) 1322-1325, DOI:
10.1080/00365521.2019.1686059 - Wirz S, Molderings GJ. A Practical Guide for Treatment of Pain in Patients with Systemic Mast Cell Activation Disease. Pain Physician. 2017;20(6):E849-E861.
- Zenker N, and Afrin LB. Utilities of Various Mast Cell Mediators in Diagnosing Mast Cell Activation Syndrome. Blood 2015; 126 (23): 5174. doi: https://doi.org/10.1182/blood.V126.23.5174.5174
Helpful Tools
Emergencies
- American Academy of Allergy Asthma and Immunology Anaphylaxis Emergency Action Plan (pdf)
- Emergency Care for Patients with Mast Cell Diseases (pdf)
- Emergency Room Protocols (pdf)
- Emergency Room Response Plan for Patients with Mast Cell Diseases (pdf)
- Medical Alert Wallet Card (pdf)
- Way to Advocate for a Child in the Emergency Room (pdf)
For Healthcare Providers
- 2020-2021, Volume 2 Special Edition for Health Care Professionals (pdf): TMS proudly presents the updated 2020-2021 Volume 2 Special Edition for Health Care Professionals. The 2020-2021 Volume 2 Special Edition covers summaries on mast cell definitions, diagnosis and classification, cytology of mast cells, tests, treatments, and medications as well as other topics.
- Mastocytosis and Mast Cell Activation Syndromes (pdf)
- Medication Reference Guide (pdf)
- The Provider Primers Series
For Adult Patients
- Accessibility: A Beginner’s Guide to Fragrance and Chemical Sensitivities
- Medical Providers
- Medication Log (pdf)
- Medication Reference Guide (pdf)
- Mood Check-in Sheet (pdf)
- Perceived Stress Scale (pdf)
- Supporting materials for explaining mast cell disease to non-health care professionals
- The MastAttack 107: The Layperson’s Guide to Understanding Mast Cell Diseases
- Videos and Webinars from The Mast Cell Society, Inc
For Kids
- Doctor Visit Preparation Form (pdf)
- Feel Good Prompts Activity (pdf)
- Medication Log (pdf)
- Mood Check-in Sheet
- The Ball of Wool Game (pdf)
- The Puzzle of You (pdf)
- Your Wellbeing Bucket (pdf)
For Parents
Resources
Presentations
- Dr. Alex Croom presents on MCAS at the POTs Masterclass 2019
- Dr Arnold Deering talks about MCAS with Samia Qader
- Dr. Bethan Myers presents on MCAS at the POTs Masterclass 2019
- Dr. Ravi Sargur presents 'Urinary Mast Cell Mediators in Mast Cell Disorders' as part of the BSACI webinar series 2021
- 'Mast cell activation' presented by Dr. Anne Maitland from the ICAHN school of medicine at Mount Sinai
- The Mast Cell Disease Primer from The Mast Cell Disease Society, Inc (pdf)
- Treatment of Allergy and Immunology Issues by Dr. Anne Maitland presented at the EDS virtual Summer conference 2020
Infographics
Books
- My Crazy Life: A Humorous Guide to Understanding Mast Cell Disorders by Daniel & Pamela Hodge
- Never Bet Against Occam: Mast Cell Activation Disease and the Modern Epidemics of Chronic Illness and Medical Complexity by LB Afrin
Organizations
Please note: The majority of books links shared are Amazon affiliate links. As an Amazon Associate, I earn commissions from qualifying purchases made through links in this post at no additional cost to you.